Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1186194-46-6 | MDL No. : | MFCD11226508 |
Formula : | C7H6BrNO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DYSLRNROALTKNA-UHFFFAOYSA-N |
M.W : | 232.03 | Pubchem ID : | 45790466 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 45.39 |
TPSA : | 59.42 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.74 cm/s |
Log Po/w (iLOGP) : | 1.65 |
Log Po/w (XLOGP3) : | 1.37 |
Log Po/w (WLOGP) : | 1.55 |
Log Po/w (MLOGP) : | -0.2 |
Log Po/w (SILICOS-IT) : | 1.41 |
Consensus Log Po/w : | 1.16 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -2.38 |
Solubility : | 0.968 mg/ml ; 0.00417 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.22 |
Solubility : | 1.4 mg/ml ; 0.00602 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.39 |
Solubility : | 0.954 mg/ml ; 0.00411 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.83 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 93349-99-6 ]
Methyl 5-bromo-6-methoxynicotinate
Similarity: 0.97
[ 41668-13-7 ]
5-Bromo-6-hydroxynicotinic acid
Similarity: 0.94
[ 717843-56-6 ]
3-Bromo-2-methoxy-5-methylpyridine
Similarity: 0.86
[ 760207-86-1 ]
3-Bromo-2-isopropoxy-5-methylpyridine
Similarity: 0.84
[ 93349-99-6 ]
Methyl 5-bromo-6-methoxynicotinate
Similarity: 0.97
[ 717843-56-6 ]
3-Bromo-2-methoxy-5-methylpyridine
Similarity: 0.86
[ 760207-86-1 ]
3-Bromo-2-isopropoxy-5-methylpyridine
Similarity: 0.84
[ 66572-55-2 ]
2-Methoxy-5-pyridinecarboxylic acid
Similarity: 0.80
[ 717843-51-1 ]
3-Bromo-2-methoxy-4-methylpyridine
Similarity: 0.79
[ 41668-13-7 ]
5-Bromo-6-hydroxynicotinic acid
Similarity: 0.94
[ 20826-04-4 ]
3-Bromo-5-pyridine carboxylic acid
Similarity: 0.83
[ 66572-55-2 ]
2-Methoxy-5-pyridinecarboxylic acid
Similarity: 0.80
[ 1190862-72-6 ]
5-Bromo-6-methylnicotinic acid
Similarity: 0.80
[ 93349-99-6 ]
Methyl 5-bromo-6-methoxynicotinate
Similarity: 0.97
[ 41668-13-7 ]
5-Bromo-6-hydroxynicotinic acid
Similarity: 0.94
[ 717843-56-6 ]
3-Bromo-2-methoxy-5-methylpyridine
Similarity: 0.86
[ 760207-86-1 ]
3-Bromo-2-isopropoxy-5-methylpyridine
Similarity: 0.84